Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus Results From the CANVAS Program

Gemma A. Figtree; Karin Radholm; Terrance D. Barrett; Vlado Perkovic; Kenneth W. Mahaffey; Dick de Zeeuw; Greg Fulcher; David R. Matthews; Wayne Shaw; Bruce Neal

doi:10.1161/CIRCULATIONAHA.119.040057

Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus Results From the CANVAS Program

Gemma A. Figtree^*
, Karin Radholm
, Terrance D. Barrett
, Vlado Perkovic
, Kenneth W. Mahaffey
, Dick de Zeeuw
, Greg Fulcher
, David R. Matthews
, Wayne Shaw
, Bruce Neal

^*Corresponding author voor dit werk

Groningen Kidney Center (GKC)

Onderzoeksoutput › Academic › peer review

137 Citaten (Scopus)

148 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	2591-2593
Aantal pagina's	3
Tijdschrift	Circulation
Volume	139
Nummer van het tijdschrift	22
DOI's	https://doi.org/10.1161/CIRCULATIONAHA.119.040057
Status	Published - 28-mei-2019

Toegang tot document

10.1161/CIRCULATIONAHA.119.040057

Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes MellitusFinal publisher's version, 54,6 KBLicentie: Taverne

Handle.net

Permanente koppeling

Citeer dit

Figtree, G. A., Radholm, K., Barrett, T. D., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Matthews, D. R., Shaw, W., & Neal, B. (2019). Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus Results From the CANVAS Program. Circulation, 139(22), 2591-2593. https://doi.org/10.1161/CIRCULATIONAHA.119.040057

@article{0b5b8129c01e42f19439967e77983a95,

title = "Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus Results From the CANVAS Program",

keywords = "canagliflozin, heart failure, randomized trial, SGLT2 inhibitor, type 2 diabetes mellitus",

author = "Figtree, \{Gemma A.\} and Karin Radholm and Barrett, \{Terrance D.\} and Vlado Perkovic and Mahaffey, \{Kenneth W.\} and \{de Zeeuw\}, Dick and Greg Fulcher and Matthews, \{David R.\} and Wayne Shaw and Bruce Neal",

year = "2019",

month = may,

day = "28",

doi = "10.1161/CIRCULATIONAHA.119.040057",

language = "English",

volume = "139",

pages = "2591--2593",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "22",

}

Figtree, GA, Radholm, K, Barrett, TD, Perkovic, V, Mahaffey, KW, de Zeeuw, D, Fulcher, G, Matthews, DR, Shaw, W & Neal, B 2019, 'Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus Results From the CANVAS Program', Circulation, vol. 139, nr. 22, blz. 2591-2593. https://doi.org/10.1161/CIRCULATIONAHA.119.040057

TY - JOUR

T1 - Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus Results From the CANVAS Program

AU - Figtree, Gemma A.

AU - Radholm, Karin

AU - Barrett, Terrance D.

AU - Perkovic, Vlado

AU - Mahaffey, Kenneth W.

AU - de Zeeuw, Dick

AU - Fulcher, Greg

AU - Matthews, David R.

AU - Shaw, Wayne

AU - Neal, Bruce

PY - 2019/5/28

Y1 - 2019/5/28

KW - canagliflozin

KW - heart failure

KW - randomized trial

KW - SGLT2 inhibitor

KW - type 2 diabetes mellitus

U2 - 10.1161/CIRCULATIONAHA.119.040057

DO - 10.1161/CIRCULATIONAHA.119.040057

M3 - Letter (Research letter)

SN - 0009-7322

VL - 139

SP - 2591

EP - 2593

JO - Circulation

JF - Circulation

IS - 22

ER -